Abstract
RIP3 is a novel gene product containing a N-terminal kinase domain that shares extensive homology with the corresponding domain in RIP (receptor- interacting protein) and RIP2. Unlike RIP, which has a C-terminal death domain, and RIP2, which has a C-terminal caspase activation and recruitment domain, RIP3 has a unique C terminus. RIP3 binds RIP through its unique C- terminal segment and by virtue of this interaction is recruited to the tumor necrosis factor (TNF) receptor-1 signaling complex. Previous studies have shown that RIP mediates TNF-induced activation of the anti-apoptotic NF-κB pathway. RIP3, however, attenuates both RIP and TNF receptor-1-induced NF- κB activation. Overexpression studies revealed RIP3 to be a potent inducer of apoptosis, capable of selectively binding to large prodomain initiator caspases.
Cite
CITATION STYLE
Xiaoqing, S., James, L., Navas, T., Baldwin, D. T., Stewart, T. A., & Dixit, V. M. (1999). RIP3, a novel apoptosis-inducing kinase. Journal of Biological Chemistry, 274(24), 16871–16875. https://doi.org/10.1074/jbc.274.24.16871
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.